SCHEMBL8317285

SCHEMBL8317285

CCOC(=O)/C=C/c1ccc(C(O)Cc2ccc(OCc3ccccc3)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.55
BACE1 P56817 4/20 0.55
NR1H4 Q96RI1 1/20 0.53
MMP1 P03956 2/20 0.52
NPC1 O15118 1/20 0.52
RAB9A P51151 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
EGFR P00533 1/20 0.52
ERBB2 P04626 1/20 0.52
MAOB P27338 1/20 0.51
CA12 O43570 2/20 0.50
CA7 P43166 2/20 0.50
CA9 Q16790 2/20 0.50
CA14 Q9ULX7 2/20 0.50
LMNA P02545 2/20 0.50
KDM4E B2RXH2 1/20 0.50
MEN1 O00255 1/20 0.50
TP53 P04637 1/20 0.50
MAPT P10636 1/20 0.50
KMT2A Q03164 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6539306 0.89 GSK3B (0.68) GSK3BBACE1NR1H4NPC1RAB9A
SCHEMBL6539315 0.89 GSK3B (0.68) GSK3BBACE1NR1H4NPC1RAB9A
SCHEMBL8317289 0.89 MMP1 (0.55) GSK3BBACE1NR1H4MMP1NPC1
SCHEMBL8320370 0.84 GSK3B (0.62) GSK3BBACE1NPC1RAB9ASMN1; SMN2
SCHEMBL14021580 0.81 NR1H4 (0.60) GSK3BBACE1NR1H4NPC1RAB9A
SCHEMBL13678668 0.81 ALDH1A1 (0.55) GSK3BBACE1NR1H4EGFRERBB2
SCHEMBL15687587 0.80 LMNA (0.77) GSK3BBACE1NPC1RAB9ASMN1; SMN2
SCHEMBL15687588 0.80 LMNA (0.77) GSK3BBACE1NPC1RAB9ASMN1; SMN2
SCHEMBL13791103 0.80 KDM4E (0.56) GSK3BBACE1NR1H4MAOBCA12
SCHEMBL8322091 0.79 RAB9A (0.55) GSK3BBACE1RAB9AMAOBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004071401-A2 HYDROXAMIC ACID DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS (HDCA) FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-26 WO disclosed